US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 4.070
  • +0.250+6.54%
Close Nov 29 13:00 ET
  • 4.210
  • +0.140+3.44%
Post 17:01 ET
435.44MMarket Cap-7826P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.254M--
--2024/Q4-- / 5.846M--
--2024/Q34.346M / 11.849M--
--2024/Q22.766M / 1.817M--
May 7, 20242024/Q12.398M / 1.929M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.254M--
--2024/Q4-- / 5.846M--
--2024/Q34.346M / 11.849M--
--2024/Q22.766M / 1.817M--
May 7, 20242024/Q12.398M / 1.929M--

Unlock Free Earnings Estimates

Aclaris Therapeutics Earnings Reports

  • Aclaris Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:34 ET

  • Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

    Nov 6 07:22 ET

  • Aclaris Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 22:20 ET

  • Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

    Aug 7 07:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data